Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:SLSNYSE:USA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeSLSSELLAS Life Sciences Group$1.63+1.9%$1.30$0.77▼$1.85$154.11M2.341.43 million shs2.78 million shsUSALiberty All-Star Equity Fund$6.71+0.7%$6.41$5.64▼$7.49$1.82B1.12729,067 shs704,829 shsA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceSLSSELLAS Life Sciences Group0.00%+4.49%+25.38%+23.48%+10.88%USALiberty All-Star Equity Fund0.00%+3.15%+10.19%-5.36%-2.40%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationSLSSELLAS Life Sciences Group0.9139 of 5 stars0.04.00.00.03.20.00.6USALiberty All-Star Equity FundN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceSLSSELLAS Life Sciences Group 0.00N/AN/AN/AUSALiberty All-Star Equity Fund 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookSLSSELLAS Life Sciences Group$1M154.11N/AN/A($0.25) per share-6.52USALiberty All-Star Equity Fund$259.99M6.99N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateSLSSELLAS Life Sciences Group-$37.34M-$0.38N/AN/AN/AN/A-629.46%-178.65%N/AUSALiberty All-Star Equity FundN/AN/A0.00∞N/AN/AN/AN/A5/19/2025 (Estimated)Latest CLIG, SLS, USA, and APAX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2025Q1 2025SLSSELLAS Life Sciences Group-$0.1067-$0.07+$0.0367-$0.07N/AN/A3/20/2025Q4 2024SLSSELLAS Life Sciences Group-$0.1067-$0.08+$0.0267-$0.08N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthSLSSELLAS Life Sciences GroupN/AN/AN/AN/AN/AUSALiberty All-Star Equity Fund$0.6810.14%-4.30%N/AN/ALatest CLIG, SLS, USA, and APAX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/14/2025USALiberty All-Star Equity Fundquarterly$0.1510.7%4/17/20254/17/20256/2/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioSLSSELLAS Life Sciences GroupN/A2.262.26USALiberty All-Star Equity FundN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipSLSSELLAS Life Sciences Group17.38%USALiberty All-Star Equity Fund9.95%Insider OwnershipCompanyInsider OwnershipSLSSELLAS Life Sciences Group1.40%USALiberty All-Star Equity Fund0.09%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableSLSSELLAS Life Sciences Group1094.55 million69.54 millionNot OptionableUSALiberty All-Star Equity FundN/A270.86 million270.61 millionNot OptionableCLIG, SLS, USA, and APAX HeadlinesRecent News About These CompaniesLiberty All-Star® Equity Fund April 2025 Monthly UpdateMay 15 at 3:03 PM | finance.yahoo.comHow the “Smart Money” Is Playing US Stocks Now (for 9.5% Dividends)May 14, 2025 | marketbeat.comUSA: A Historical Underperformer, But Value-Orientation Might Be AppealingMay 11, 2025 | seekingalpha.comThe $47,120 Mistake: Why 60/40 Portfolios Are Losing in the Tariff TurmoilMay 4, 2025 | marketbeat.comLiberty All-Star Equity Fund (NYSE:USA) Short Interest UpdateApril 30, 2025 | marketbeat.comShort Interest in Liberty All-Star Equity Fund (NYSE:USA) Increases By 37.4%April 21, 2025 | marketbeat.comLiberty All-Star® Equity Fund March 2025 Monthly UpdateApril 15, 2025 | prnewswire.comLiberty All-Star® Equity Fund Declares DistributionApril 7, 2025 | prnewswire.comLiberty All-Star® Equity Fund February 2025 Monthly UpdateMarch 14, 2025 | prnewswire.comUSA: Delivers A High Yield Without Sacrificing Tech ExposureFebruary 25, 2025 | seekingalpha.comLiberty All-Star® Equity Fund January 2025 Monthly UpdateFebruary 14, 2025 | prnewswire.comCTBC Bank Contributes $300,000 to Support LAEDC's Small Business Recovery Efforts Following Los Angeles WildfiresFebruary 13, 2025 | businesswire.comLiberty All Star Equity Closed FundFebruary 9, 2025 | uk.investing.com2 Bright Yields Up To 10%January 25, 2025 | seekingalpha.comUSA: Why I Just Doubled My PositionJanuary 16, 2025 | seekingalpha.comLiberty All-Star® Equity Fund December 2024 Monthly UpdateJanuary 14, 2025 | prnewswire.comLiberty All-Star® Equity Fund Declares DistributionJanuary 13, 2025 | prnewswire.comUSA: Better Alternatives Available (Downgrade)January 10, 2025 | seekingalpha.com(USA) Long Term Investment AnalysisJanuary 8, 2025 | news.stocktradersdaily.comHow to Take Advantage of moves in (USA)December 28, 2024 | news.stocktradersdaily.comLiberty All-Star® Equity Fund November 2024 Monthly UpdateDecember 13, 2024 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCLIG, SLS, USA, and APAX Company DescriptionsSELLAS Life Sciences Group NASDAQ:SLS$1.63 +0.03 (+1.88%) Closing price 05/16/2025 04:00 PM EasternExtended Trading$1.62 0.00 (-0.31%) As of 05/16/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase 3 clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009, a highly selective small molecule CDK9 inhibitor, currently under Phase 1 clinical trials. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.Liberty All-Star Equity Fund NYSE:USA$6.70 +0.05 (+0.68%) Closing price 05/16/2025 03:59 PM EasternExtended Trading$6.70 0.00 (0.00%) As of 05/16/2025 06:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Liberty All Star Equity Fund is a closed-ended equity mutual fund launched and managed by ALPS Advisers, Inc. The fund is co-managed by Aristotle Capital Management, LLC, Pzena Investment Management, LLC, Delaware Investments Fund Advisers, Sustainable Growth Advisers, LP, and TCW Investment Management Company. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in value and growth stocks of large cap companies. The fund benchmarks the performance of its portfolio against the Lipper Large-Cap Core Mutual Fund Average, the Dow Jones Industrial Average, the NASDAQ Composite Index, and the S&P 500 Index. Liberty All Star Equity Fund was formed on October 31, 1986 and is domiciled in the United States. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/12 - 05/16 Retail Investors Are Betting Big on Rocket Lab—Should You Too? Meta's 5 Key Pillars for AI Growth—Zuckerberg's Bold Vision Taiwan Semiconductor Stock Is The Gift That Keeps on Giving GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine Alibaba's Earnings Just Changed Everything for the Stock Plug Power: Is Q1 Noise An Opportunity for Accumulation? Cisco Stock Eyes New Highs in 2025 on AI, Earnings, Upgrades Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
